baber/WOPTO huggingface dataset:
Patent AU-2001276778-B2 (AU)
Title: Abrasive item for cleaning with scented abrasive fibres
Inventor: VAZQUEZ EFREN PEREZ
IPC: A47K7/02
Filed: 2001-07-13
Granted: 2007-02-15
Abstract: Abrasive cleaning article (A) for treating domestic or industrial surfaces or for skin care comprises: (i) a three-dimensional non-woven network (N); (ii) abrasive, inorganic or polymeric particles (P); and (iii) the new feature, microcapsules (M). Both P and M are dispersed in N and are adherent to the non-woven material. Independent claims are also included for the following: (1) Method for preparing (A); and (2) Microcapsules containing perfume prepared by evaporating a mixture comprising 35-40% decamethyl cyclopentasiloxane, 25-30% oil-based fragrance, 10-15% diethyl phthalate, 15-25% urea, less than 2% water, less than 2% octamethyl cyclotetrasiloxane, less than 1% methyl salicylate and less than 0.04% formaldehyde.
Patent AU-2001277595-B2 (AU)
Title: Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
Inventor: COSTA HERVE DA
IPC: A61P15/00
Filed: 2001-07-16
Granted: 2006-08-17
Abstract: The invention relates to compounds of formula (I): wherein: B represents a hydrogen atom, a COOR group, a CONRR' group, or a (C<SUB>1</SUB>-C<SUB>6</SUB>)alkyl group substituted by a COOR, CONRR' or OR group, G<SUB>1 </SUB>represents a -X'-(CH<SUB>2</SUB>)<SUB>n</SUB>-X-(CH<SUB>2</SUB>)<SUB>m</SUB>-X''- chain wherein X, X', X'', n and m are as defined in the description, Cy represents a grouping of formula (II) or (III): G<SUB>2 </SUB>represents an alkylene chain as defined in the description, and A represents a NRCOR', NRCSR', CONRR', CSNRR', NRCONR'R'' or NRCSNR'R'' group.
Patent AU-2001281056-B2 (AU)
Title: Multiple flavor beverage dispensing air-mix nozzle
Inventor: JOHN D SANTY JR
IPC: G01F13/00
Filed: 2001-08-06
Granted: 2005-04-07
Abstract: In a beverage dispensing nozzle, a cap member includes first, second, and third beverage syrup inlet ports coupled to a respective first, second, and third beverage syrup sources and a mixing fluid inlet port coupled to a mixing fluid source. A first annulus coupled with the cap member includes discharge channels, wherein the first beverage syrup inlet port communicates beverage syrup to the discharge channels for discharge from the beverage dispensing nozzle. A second annulus disposed within the first annulus and coupled with the cap member includes discharge channels, wherein the second beverage syrup inlet port communicates beverage syrup to the discharge channels for discharge from the beverage dispensing nozzle. A third annulus disposed within the second annulus and coupled with the cap member includes discharge channels, wherein the third beverage syrup inlet port communicates beverage syrup to the discharge channels for discharge from the beverage dispensing nozzle. An outer housing coupled to the cap member defines a mixing fluid channel with the first annulus, wherein the mixing fluid inlet port communicates mixing fluid to the mixing fluid channel for discharge from the beverage dispensing nozzle and mixing with exiting beverage syrup.
Patent AU-2002210652-B2 (AU)
Title: Electric glass melting furnace, with pivoting wall elements
Inventor: COTONNEC HERVE
IPC: C03B5/42
Filed: 2001-10-17
Granted: 2006-08-24
Abstract: An electric glass-melting furnace including a floor made of refractory materials, four lateral walls, an upper roof, a glass composition feeder, and an output channel for the melted glass. The furnace includes a set of elements pivoting about horizontal axes and placed at the periphery of the furnace between at least one of the lateral walls and the roof.
Patent AU-2002239638-B2 (AU)
Title: Turbulent air cleaning method and apparatus for catheter assemblies
Inventor: CARLSEN WAYNE D
IPC: A61M16/04
Filed: 2001-12-17
Granted: 2007-07-26
Abstract: A method and apparatus are provided for cleaning a catheter tube (34). The distal end portion (36) of the tube has a distal opening (38) and at least one side opening (40) adjacent to the distal opening. The distal end of the tube is disposed in a closed chamber (62) with the distal opening generally opposite from a first orifice defined in the chamber. A liquid is introduced into the chamber and is drawn into the distal opening in the tube, for example by a suction force. A different fluid medium, such as air, is drawn through the first orifice and into the distal opening in the tube. A turbulent flow path is established with the fluid medium wherein the medium is drawn through the first orifice, into the distal opening in the tube, out the side opening in the tube, and back into the distal opening in the tube. This turbulent flow path enhances the cleaning action of the liquid introduced into the chamber for cleaning the distal end portion of the tube within the chamber.
Patent AU-2002317599-B2 (AU)
Title: GLP-1 exendin-4 peptide analogs and uses thereof
Inventor: GREIG NIGEL H
IPC: A61K38/26
Filed: 2002-07-30
Granted: 2008-04-03
Abstract: The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.
Patent AU-2002328660-B2 (AU)
Title: Vanadium / polyhalide redox flow battery
Inventor: SKYLLAS-KAZACOS MARIA
IPC: H01M8/04186
Filed: 2002-08-23
Granted: 2008-01-10
Abstract: The invention relates to a redox flow cell containing a polyhalide/halide redox couple in the positive half-cell electrolyte and a V(III)/V(II) redox couple in the negative half-cell electrolyte. The invention also relates to a method of producing electricity by discharging the fully charged or partially charged redox flow cell, and a method of charging the discharged or partially discharged redox flow cell.
Patent AU-2002333211-B2 (AU)
Title: Human coagulation factor VII polypeptides
Inventor: PERSSON EGON
IPC: C12N1/19
Filed: 2002-09-26
Granted: 2008-05-08
Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment. The variant comprises at least two substitutions; i) replacement of L305 and ii) replacement of at least one of the following amino acids selected from the groupconsisting of K157, k337, D334, S336, V158, E296 and M298.
Patent AU-2003201055-B2 (AU)
Title: Detection of mutations
Inventor: LUNDEN ANNE
IPC: C12N9/02
Filed: 2003-01-09
Granted: 2007-11-29
Abstract: The present invention relates to a polypeptide which is flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity with the polypeptide sequence SEQ ID NO: 15, in particular to a polypeptide which is a functionally altered mutant of flavin-containing mono oxygenase 3 (FMO3) leading to a buildup of trimethylamine in an animal. Further, the invention relates to nucleic acid sequences encoding said polypeptide, and to the complements of such nucleic acid sequences. Such nucleic acid sequences and fragments thereof may be useful e.g. as primers. The invention further relates to various methods for determining the presence in e.g. a nucleic acid sample of a nucleic acid sequence encoding a mutated FMO3 polypeptide.
Patent AU-2003208700-B2 (AU)
Title: Near infrared fluorescent contrast agent and method for fluorescence imaging
Inventor: EGUCHI HIROAKI
IPC: C07D209/14
Filed: 2003-03-07
Granted: 2007-12-20
Abstract: A near infrared fluorescent contrast agent which is excellent in permeability in a living tissue and enables specific imaging of tumor and/or blood vessel, comprising a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R7, and R8 represent a C1-C10 alkyl group or the like; R3, R4, R5, R6, R9, R10, R11, and R12 represent a hydrogen atom, a C1-C6 alkyl group, an aryl group or the like; X1 and X2 represent a C1-C15 alkyl group or an aryl group and X1 and X2 in total have 0 to 4 carboxyl groups; m1, m2, and m3 represents 0 or 1; L1 to L7 independently represent a methine group; M represents a hydrogen atom, a metal, or a quaternary ammonium salt; and n represents an integer of 1 to 7 necessary for neutralizing charge.
Patent AU-2003233880-B2 (AU)
Title: Envelope for optical fibres
Inventor: VANWINKEL FREDDY
IPC: G02B6/44
Filed: 2003-05-07
Granted: 2007-12-13
Abstract: Enclosure and method for sealingly enclosing a space into and/or from which at least one optical fiber is fed to connect to at least one optical component, by providing a flexible protective sheet of substantially moisture resistant material having a pair of sealing strips; and folding and sealing the sheet around the optical component to provide an envelope enclosing the component with the optical fiber(s) sealed between the sealing strips. The invention also concerns an enclosure into and/or from which the optical fibers pass through an aperture, which is sealed by an adherent patch, or flap with the fibers sealed between the exterior surface of the enclosure and an overlying portion of the patch or flap.
Patent AU-2003280154-B2 (AU)
Title: Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
Inventor: LU XIAN-PING
IPC: A61K31/335
Filed: 2003-11-21
Granted: 2009-04-02
Abstract: Disclosed is the preparation and pharmaceutical use of substituted arylalcanoic acid derivatives of Formula I, wherein ring A, ring B, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, X, Alk<SUP>1</SUP>, Alk<SUP>2</SUP>, Ar<SUP>1</SUP>, and Ar<SUP>2 </SUP>are as defined in the specification. These compounds, as selective agonists activating peroxisome proliferator-activated receptors (PPAR), in particularly the RXR/PPARalpha, RXR/PPARgamma, and RXR/PPARdelta heterodimers, are useful in the treatment and/or prevention of type 2 diabetes and associated metabolic syndrome such as hypertension, obesity, insulin resistance, hyperlipidemia, hyperglycemia, hypercholesterolemia, atherosclerosis, coronary artery disease, and other cardiovascular disorders with improved side effects profile commonly associated with conventional PPARgamma agonists.
Patent AU-2004319170-B2 (AU)
Title: System and method for generating reproducible session keys
Inventor: BROWN MICHAEL S
IPC: H04L9/00
Filed: 2004-11-26
Granted: 2008-05-01
Abstract: A system and method for generating reproducible session keys in a wireless messaging system. The session key is generated based on a hash of a message itself, optionally concatenated with additional information. Since the local server stores the message, it can easily regenerate the same session key in response to each MORE request. The method of the invention can be implemented with the stored original message, a public key, and an algorithm for generating the session key based on a hash of the message.
Patent AU-2005204601-B2 (AU)
Title: Bolt that can be pressed into a metal sheet in a torsion-proof and ejection-proof manner
Inventor: SCHRAER THORSTEN
IPC: F16B33/00
Filed: 2005-01-12
Granted: 2010-07-08
Abstract: Disclosed is a bolt ( 10 ) that can be pressed into a metal sheet in a torsion-proof and ejection-proof manner and comprises a head ( 12 ). The side of the head ( 12 ) facing the metal sheet after being inserted is provided with radially arranged webs ( 22 ) which are pressed in when being inserted into the metal sheet. A cylindrical winding support ( 14 ) is disposed in the center of the head ( 12 ). Said winding support ( 14 ) extends through the metal sheet and protrudes on the other side thereof while being provided with a circumferential annular groove ( 20 ) near the side of the head ( 12 ) that faces the metal sheet in the set state. The sheet metal material that is displaced during the setting process can be pressed into said annular groove ( 20 ). All or part of the side of the head ( 12 ) facing the metal sheet is provided with a rubber-elastic sealing material ( 110 ).
Patent AU-2005211154-B2 (AU)
Title: Underpants
Inventor: EHMSEN LENA
IPC: A41D13/12
Filed: 2005-02-04
Granted: 2009-10-29
Abstract: The present invention relates to a pair of underpants comprising a front part, a back part, a crotch part and two leg holes delimited by the parts, and releasable connecting means for connecting the crotch part to the front part and allowing an opening to be formed in the crotch area, said releasable connecting means extending from one leg hole to the other and comprising two parts one overlapping the other in the closed condition wherein the ends of a part of said releasable connecting means are provided with flexible protection means.
Patent AU-2005220247-B2 (AU)
Title: Acetabular rim cutter
Inventor: LAVIEILLE PHILIPPE
IPC: A61F2/34
Filed: 2005-10-07
Granted: 2011-05-12
Abstract: An acetabular rim cutter comprising an annular cutting face provided on a rotatable carrier, means for attaching the carrier to a rotation means and a guide element axially aligned with said cutting face to locate and align said cutting face on the acetabulum with which it is to be used, said guide element being axially movable in relation to the cutting face, and resilient means are provided for biasing it axially away therefrom.
Patent AU-2005221656-B2 (AU)
Title: Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
Inventor: RADER DANIEL J
IPC: A61K31/445
Filed: 2005-03-07
Granted: 2011-06-23
Abstract: The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an effective amount of an MTP inhibitor to inhibit hyperlipidemia and/or hypercholesterolemia in said subject, wherein said administration comprises an escalating series of doses of the MPT inhibitor. In some embodiments the method comprises administering at least three stepwise, increasing dosages of the MPT inhibitor to the subject. In some embodiments, the method further comprises the administration of one or more other lipid modifying compounds.
Patent AU-2006253941-B2 (AU)
Title: High affinity Melan-A T cell receptors
Inventor: JAKOBSEN BENT KARSTEN
IPC: C07K14/725
Filed: 2006-05-31
Granted: 2012-04-12
Abstract: The present invention provides TCRs having an affinity (K) of less than or equal to 3μM, and/or an off-rate (k) of 1x10 S or slower, for the AAGIGILTV-HLA- A* 0201 complex.. Such TCRs are useful, either alone or associated with a therapeutic agent, for targeting cancer cells presenting that complex.
Patent AU-2006270591-B2 (AU)
Title: Door opener
Inventor: SCHEIB MICHAEL KEVIN
IPC: E06B9/68
Filed: 2006-07-20
Granted: 2012-03-08
Abstract: A barrier movement operator having a barrier curtain having on end support and disposed on an axle and a final drive connected to a motor and mounted for rotation about the axle. The final drive comprises a pair of mounting receptacles spaced apart from one another and disposed a substantially equal distance from an axis of rotation of the final drive about the axle. Each of the receptacles comprises a member for receiving and retaining an extension by which rotational forces are conveyed to the end support of the curtain barrier. The invention is also the drive assembly and a curtain door assembly.
Patent AU-2006273203-B2 (AU)
Title: Strain of turkey tail mushroom, extract from the same, and use of the same
Inventor: MORI NOBUO
IPC: A61P9/12
Filed: 2006-07-28
Granted: 2011-07-28
Abstract: Disclosed is a strain of turkey tail mushroom () having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, anti-mutagenic effect, anti-tumor effect, anti-hypertensive effect and immunomodulating effect. When the strain is used in combination with a microalga or other basidiomycete, the effect of the strain is improved synergistically. The strain has a high safety, is less likely to cause an adverse side effect even when used continuously for a prolonged period of time, and can be used effectively in a beverage, cosmetic, pharmaceutical or the like that is intended to be used for the prevention/improvement of an inflammation, an allergy, a tumor or other disease. The strain has extremely increased hypha growth property and shows extremely higher physiological functions compared to conventional strains and therefore can be used stably.
Patent AU-2006322342-B2 (AU)
Title: Pharmaceutical compositions comprising cyclosporin
Inventor: KELLER MANFRED
IPC: A61K38/13
Filed: 2006-11-29
Granted: 2012-05-24
Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.
Patent AU-2007265467-B2 (AU)
Title: Glycine transporter-1 inhibitors
Inventor: WENYUAN QIAN
IPC: C07D243/08
Filed: 2007-06-26
Granted: 2011-09-01
Abstract: The present invention provides compounds of formula (I) that are glycine transporter 1 (hereinafter referred to as GlyT-1) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of GlyT1 such as cognitive disorders associated with Schizophrenia, ADHD (attention deficit hyperactivity disorder), MCI (mild cognitive impairment), and the like. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Patent AU-2007276774-B2 (AU)
Title: Patient support with welded materials
Inventor: LINA CESAR Z
IPC: A47C21/04
Filed: 2007-07-24
Granted: 2013-10-03
Abstract: Apparatus, systems, and methods to support a patient or other person include a first material that is substantially air impermeable welded to a second material that is substantially air permeable and liquid impermeable. The first material may also be liquid and vapor impermeable and the second material may be vapor permeable. Exemplary embodiments may include an inflatable enclosure formed from a sheet of the first material with an aperture, and the second material may cover a portion of the aperture.
Patent AU-2007290415-B2 (AU)
Title: Inflatable surgical retractor
Inventor: DESHMUKH VIVEK R
IPC: A61B1/32
Filed: 2007-08-31
Granted: 2013-09-26
Abstract: An expandable surgical retractor for minimally invasive surgical applications is disclosed. The expandable retractor, preferably in the form of an inflatable balloon retractor, is. inserted in a surgical corridor and expanded to the desired size and shape. The retractor of the present invention is amenable to many shapes including cylindrical, conical with the base at the. depth of the corridor, hourglass, and crescent and are dictated by the surgeon's needs. Cooling of the retractor allows the retractor to maintain the expanded characteristic. The expanded relatively rigid retractor provides an ideal corridor for surgical applications. In a preferred embodiment, a • second retractor, of the invention, can be placed at a greater depth through the first placed retractor; the "telescoping" effect rapidly provides greater exposure with minimal manipulation. Following surgery, such retractor(s) can be removed in a manner that minimizes bleeding and tissue damage. One such method is reheating to soften and restore the retractor to its unexpanded size. Or, laterally placed perforations allow for fracturing of the retractor by bo vie cautery, facilitating removal by "unzipping" the retractor.
Patent AU-2007299621-B2 (AU)
Title: Novel enhanced systems, processes and methodologies for producing clean water and products thereby
Inventor: BRUFF MATTHEW JASON
IPC: C02F1/04
Filed: 2007-09-21
Granted: 2012-04-05
Abstract: Improved methods for use of AltelaRain™ based processes (carrier-gas humidification/dehumidification [HDH] or dewvaporization) enable production of clean water, derived in part from models generated and tested with produced water from the oil and gas industries, which likewise address industrial waste water remediation and generally facilitate the time and cost efficient disposal of waste waters from a plurality of industries ranging from food and wine production to novel enhanced efficiencies within the oil and gas industries themselves. High efficiency carrier gas HDH thermal distillation functions without membranes, at ambient or near ambient pressures with no required pre- or post-treatment, and economies of scale to leverage a plastics-based processing platform. Industrial waste water including that generated by the food, wine, and beverage industries, is likewise ameliorated according to the instant teachings.
Patent AU-2007310604-B2 (AU)
Title: Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
Inventor: DAVIES STEPHEN JOHN
IPC: C07D475/00
Filed: 2007-10-19
Granted: 2012-02-02
Abstract: Compound of formula (I) are inhibitors of Polo-like kinases (PLKs), and are useful in treatment of cell proliferative diseases: wherein R and R are hydrogen, or an optionally substituted (C-C)alkyl, (C2- C)alkenyl, (C-C)alkynyl or (C-C)cycloalkyl group; R and R' are independently selected from hydrogen, -CN, hydroxyl, halogen, optionally substituted (C-C) alkyl, (C- C)alkenyl, (C-C)alkynyl or (C-C)cycloalkyl, -NRR or C-C alkoxy, wherein R and R are independently hydrogen or optionally substituted (C-Calkyl; ring A is an optionally substituted mono- or bi-cyclic carbocyclic or heterocyclic ring or a ring system having up to 12 ring atoms; T is a radical of formula R-L -Y- wherein R is an alpha amino acid or alpha amino acid ester motif, linked to ring A by linker R-L-Y- as defined in the claims.
Patent AU-2007339977-B2 (AU)
Title: Apparatus and method for providing an adjustable positive stop in space
Inventor: KANG HYOSIG
IPC: B25J9/10
Filed: 2007-12-21
Granted: 2013-08-01
Abstract: A method and apparatus for constraining motion of an end-effector in space. In one embodiment, the apparatus comprises a mechanical positioner and first and second stops. The first and second stops are controllable by a drive mechanism to constrain movement of the mechanical positioner and thereby to constrain the ability of a user to manipulate an end-effector outside a predetermined range of motion. The first and second stops are further controllable by the drive mechanism to permit movement of the end-effector within the predetermined range of motion.